Anthropic Could Be the First Frontier AI Lab to IPO — Bankers Are Lining Up Investors

Anthropic, the AI lab behind Claude, is reportedly moving toward an initial public offering as soon as October 2026. On July 15, 2026, CNBC reported that the banks leading the deal — Morgan Stanley and Goldman Sachs, with JPMorgan involved — have begun scheduling investor meetings, an early step before a formal roadshow. The context is confirmed and unusually large: Anthropic filed a confidential draft S-1 with the SEC on May 31, 2026, its Series H closed at a reported $965 billion valuation, and its run-rate revenue has been cited at roughly $47 billion. What is not confirmed is the timing. Anthropic has not announced an IPO date, a share count, or a price, and the “as soon as October” window comes from people familiar with the process, not from the company.

Here is the distinction that matters for this story, and the one we hold to throughout: the money and the paperwork are on the record; the calendar is reporting. That gap is exactly where investors get burned, so we keep it visible.

The Gist

• The confirmed part: Anthropic confidentially filed a draft registration statement (Form S-1) with the SEC on May 31, 2026, and disclosed the filing on June 1. That is an official Anthropic disclosure, not a rumor.
• The reported part: Bankers are lining up investor meetings for a listing that could come as soon as October 2026, according to CNBC and Bloomberg sources. No date is set.
• The valuation flip: Anthropic's Series H closed at a reported $965 billion post-money valuation, above OpenAI's roughly $852 billion — the first time Anthropic has been valued higher.
• The revenue curve: Reported run-rate revenue climbed from about $9 billion at the end of 2025 to roughly $30 billion in April 2026 and about $47 billion by late May 2026.
• Why it could matter: With OpenAI reportedly pushing its own IPO toward 2027, Anthropic could become the first frontier model lab to trade publicly — a reported outcome, not a done deal.

What Actually Happened on July 15

The trigger for this cycle of coverage was narrow and specific. On July 15, 2026, CNBC reported that bankers leading Anthropic's offering had begun setting up meetings between prospective investors and company executives. In IPO mechanics, that is the step before a formal roadshow: banks “sound out” demand, gauge how much interest exists and at what price, and calibrate the eventual pitch before any public filing goes effective.

The lead underwriters were reported earlier. In June 2026, Bloomberg and PYMNTS reported that Anthropic had picked Morgan Stanley and Goldman Sachs to lead the IPO, with JPMorgan also on the deal. None of that has been announced by Anthropic itself. The company's only on-the-record move on the IPO front is the confidential filing.

That filing is the anchor. On its own newsroom, Anthropic said it had “confidentially submitted a draft registration statement on Form S-1 to the SEC” on May 31, 2026, adding the standard caveat that any offering “will depend on market and other conditions” and that the number of shares and the price range had not been set. CNBC and TechCrunch covered the filing the next day.

One Confirmed Fact, Several Reported Ones

It is worth separating the pieces, because they carry very different weight.

On the record (Anthropic-disclosed): the confidential S-1 filed May 31, 2026; the Series H raise; and the run-rate revenue figures Anthropic executives have cited publicly. Reported (press sources, not Anthropic): the choice of lead banks, the July 15 investor meetings, and the “as soon as October” listing window. A confidential draft S-1 gives a company the option to go public after the SEC completes its review; it is not a commitment to a date, and companies routinely file confidentially and then wait months, or pull back entirely.

We flag this because the headline number people will remember — “Anthropic is going public in October” — is the least certain part of the story. The most certain parts are the ones that are easy to skim past: a real SEC filing and a real, very large funding round. When a private company is being priced near a trillion dollars, the difference between “filed” and “listing in October” is not a technicality.

How Anthropic's Valuation Passed OpenAI

The financial backdrop is what makes the timing plausible. In late May 2026, Anthropic closed a Series H that it valued at a reported $965 billion post-money, on the back of a $65 billion raise led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital. We covered that round in detail in our Series H analysis. Multiple outlets, including Al Jazeera and CNBC, framed it as Anthropic overtaking OpenAI to become the most valuable private AI company.

The comparison depends on two numbers, so both are worth stating explicitly. Anthropic's reported figure is $965 billion. OpenAI's most recent reported private valuation is roughly $852 billion, set in late March 2026 after a record $122 billion funding round. On those two reported marks, Anthropic sits about $113 billion ahead — the first time it has led. Both figures are private-market valuations struck in financing rounds, not public-market prices, and different secondary sources have cited OpenAI at lower marks; we use the $852 billion round figure because it is the most recent primary raise.

Valuation alone does not decide who lists first, but it changes the negotiating posture. A lab that can credibly claim the top private valuation and a filed S-1 has more freedom to pick its moment. That is the strategic story underneath the July 15 meetings: not that October is certain, but that Anthropic has assembled the pieces — paperwork, banks, and a headline valuation — that let it move quickly if it chooses to.

The Revenue Curve Underwriting the Story

The reason investors are taking an October window seriously is the shape of Anthropic's revenue. The company's run-rate revenue — an annualized snapshot of the most recent period, not trailing annual bookings — has been reported at roughly $9 billion at the end of 2025, about $30 billion in April 2026, and approximately $47 billion by late May 2026. Simon Willison and MLQ both tracked the $47 billion figure, which Anthropic president Daniela Amodei has defended publicly ahead of the filing.

Two caveats keep this honest. First, run-rate is forward-looking by construction: a company that annualizes a strong recent month will report a number well above what it has actually banked over the trailing year. Second, the growth is genuinely steep — reporting cited by VentureBeat put the earlier jump to a $30 billion run rate at roughly 80x growth — but steepness is what makes the valuation both compelling and fragile. Much of it is credited to Claude Code, Anthropic's coding agent, which sits at the center of our best AI coding tools roundup; you can read our hands-on take on Claude Code and the flagship Claude Opus 4.8 model that powers much of it.

The commercial momentum is not only about model releases. Anthropic also overtook OpenAI on U.S. business adoption on at least one dataset earlier in 2026, a shift we broke down in our Ramp adoption analysis. Enterprise traction is the kind of signal public-market investors weigh more heavily than benchmark scores, and it is part of why the cheaper, agent-friendly Claude Sonnet 5 matters to the revenue story as much as the flagship does.

Why October, and Why It Could Beat OpenAI to the Bell

The reason October keeps coming up is competitive, not just procedural. OpenAI filed its own confidential S-1 around May 22, 2026, initially targeting a fall listing at a valuation between $852 billion and more than $1 trillion — a filing we analyzed in our OpenAI S-1 breakdown. But by late June, reporting indicated OpenAI was leaning toward delaying its debut to 2027, with its finance chief reportedly eyeing that later window and Sam Altman said to view any listing below a $1 trillion valuation as a “non-starter.”

If that delay holds and Anthropic's October window materializes, Anthropic would become the first frontier model lab to trade publicly. That would be a genuine milestone — but note how many conditionals it takes to get there. It requires OpenAI to keep waiting, Anthropic to actually price a deal, and markets to cooperate. We wrote about how both founders softened their public messaging right before this run of IPO timing in this opinion piece; the timing of narrative and the timing of filings tend to move together.

The 2026 AI IPO Supercycle

Anthropic is not filing into a vacuum. 2026 has turned into the most crowded AI listing pipeline on record, and the peers set the tape Anthropic will be measured against.

OpenAI has a confidential S-1 on file and a reported 2027 lean. DeepSeek, the Chinese lab whose low-cost models jolted the market in early 2026, is preparing its own path to the public markets: on July 15, 2026, Reuters reported DeepSeek was planning a fresh raise at roughly $74 billion (about 500 billion yuan) ahead of a potential onshore IPO on Shanghai's STAR Market, weeks after closing its first external round of about $7.4 billion. And the broader supercycle stretches beyond pure-play AI: SpaceX has been reported to be preparing a public listing, and the chipmaker Cerebras already priced above its range in a Nasdaq debut earlier in 2026, a deal we covered in our Cerebras IPO report.

The significance for Anthropic is timing risk in both directions. Going first means setting the benchmark and capturing scarce investor attention; it also means being the price-discovery experiment for an entire category with no public comparable. Whoever lists first effectively tells the market what a frontier AI lab is worth.

What Could Still Derail It

Several things could push the timeline right or reset the price. The SEC review of a confidential draft can run long, especially for a company with an unusual revenue-recognition profile and heavy related-party dynamics — some of Anthropic's largest backers are also its compute suppliers, a circularity reporters have already flagged. Market conditions can close a window in days. And the gap between a $965 billion private mark and what public investors will actually pay is the central unknown; private rounds are negotiated among insiders, while an IPO is priced by a far broader and more skeptical pool.

There is also the accounting question that trailed the bank selection: how much of that run-rate revenue is durable, recurring, and recognized in a way public-market auditors and investors will accept. None of this makes an October listing implausible. It makes it contingent — which is the whole point of keeping “reported” attached to the date.

Our Take

I think the most useful way to read July 15 is as confirmation of intent, not confirmation of schedule. Anthropic has done the expensive, deliberate things — filed the S-1, named the banks, started meeting investors — that a company does when it genuinely intends to list. We have watched this lab move faster than its own guidance repeatedly over the past year, so I would not bet against an aggressive timeline. But I also would not write “Anthropic IPOs in October” as fact, because no one, including Anthropic, has said that.

For disclosure: we have no affiliate relationship with Anthropic, its bankers, or any party to this potential offering, and nothing here is investment advice. We do use Claude tools daily, which shapes our read on the revenue story but not our skepticism about the calendar.

What would prove me wrong? If Anthropic pulls or indefinitely stalls the process — a confidential filing with no follow-through — then July 15 was banks testing the water on a deal that never priced, and the “first frontier lab to list” narrative moves to whoever actually rings the bell. That is a real possibility, and it is why the confirmed facts, not the reported date, are what we would anchor any decision to.

What to Watch Next

• A public S-1. The confidential draft going public — with real financials, share count, and risk factors — is the moment the story stops being reported and becomes documented.
• Price range and roadshow dates. These convert “as soon as October” into an actual calendar.
• OpenAI's next move. If OpenAI reaffirms a 2027 delay, Anthropic's first-mover path widens; if OpenAI accelerates, the race tightens.
• DeepSeek's onshore raise. A completed $74 billion round would confirm the supercycle is global, not just a U.S. phenomenon.

Sources

• CNBC — Anthropic moves closer to mega-IPO as bankers line up investor meetings (July 15, 2026)
• Bloomberg — Morgan Stanley, Goldman Sachs to Lead Anthropic IPO (June 3, 2026)
• Anthropic — Confidential draft S-1 submitted to the SEC (May 31, 2026)
• CNBC — Anthropic confidentially files IPO prospectus with SEC (June 1, 2026)
• Al Jazeera — Anthropic soars to $965bn valuation, leapfrogging OpenAI (May 29, 2026)
• MLQ — Anthropic's annualized revenue hits $47B (2026)
• Reuters — DeepSeek to raise fresh capital at $74 billion valuation ahead of onshore IPO (July 15, 2026)

Frequently Asked Questions